Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: The GOMAP study

Mamakou, V; Hackinger, S; Zengini, E; Tsompanaki, E; Marouli, E; Serafetinidis, I; Prins, B; ... Zeggini, E; + view all Mamakou, V; Hackinger, S; Zengini, E; Tsompanaki, E; Marouli, E; Serafetinidis, I; Prins, B; Karabela, A; Glezou, E; Southam, L; Rayner, NW; Kuchenbaecker, K; Lamnissou, K; Kontaxakis, V; Dedoussis, G; Gonidakis, F; Thanopoulou, A; Tentolouris, N; Zeggini, E; - view fewer (2018) Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: The GOMAP study. BMC Psychiatry , 18 , Article 249. 10.1186/s12888-018-1826-4 . Green open access

https://ift.tt/2PyYAf5